Search Within

Subhiksha Nandakumar

Formats
  1. Journal Article (33)
  2. Meeting Abstract (32)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (53)
  3. GSK Faculty (50)
  4. Human Oncology and Pathogenesis Program (47)
  5. Sloan Kettering Institute Postdocs (47)
  6. Genitourinary Oncology Service (43)

More Groups

People
  1. Nikolaus Schultz (30)
  2. Philip Kantoff (26)
  3. Michael Berger (22)
  4. Ying Mazzu (21)
  5. David Solit (20)
  6. Goutam Chakraborty (20)

More People

Years
  1. 2025 (4)
  2. 2024 (15)
  3. 2023 (10)
  4. 2022 (13)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Cancer Research (11)
  2. Clinical Cancer Research (11)
  3. Journal of Clinical Oncology (11)
  4. Neuro-Oncology (7)
  5. Molecular Oncology (4)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Association for Cancer Research (25)
  2. American Society of Clinical Oncology (11)
  3. Oxford University Press (8)
  4. Nature Publishing Group (5)
  5. FEBS Press (4)
  6. Lippincott Williams & Wilkins (3)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination treatment of PARP and SRC inhibitors in BRCA2 mutated prostate cancer
    Meeting Abstract

    Khan, N.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Atiq, M.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Meeting Abstract

    Atiq, M.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hypermethylation of miR193b reactivates master drivers of the poor prognosis prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Armenia, J.; Jehane, L.; Lee, G. S.; Chakraborty, G.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer
    Meeting Abstract

    Chakraborty, G.; Atiq, M.; Nandakumar, S.; Mazzu, Y. Z.; Armenia, J.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Chakraborty, G.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Kantoff, P. W.
    Molecular Oncology (2019)

    Fulltext@MSK | Save
  • A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Coggins, S. A.; Nandakumar, S.; Gerke, T. A.; Pomerantz, M. M.; Qiu, X.; Zhao, H.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save